 NEWTOWN, Pa., Dec. 05, 2022 GLOBE NEWSWIRE The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of all purchasers of Eiger BioPharmaceuticals, Inc. Eiger NASDAQ: EIGR common stock. Investors who purchased Eiger common stock between March 10, 2021 and October 4, 2022 the Class Period may move the U.S. ... The post INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Eiger BioPharmaceuticals, Inc. NASDAQ: EIGR... 